FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2960420328> ?p ?o ?g. }

• W2960420328 abstract "Glioblastoma is the most aggressive and most lethal primary brain tumor in the adulthood. Current standard therapies are not curative and novel therapeutic options are urgently required. Present knowledge suggests that the continued glioblastoma growth and recurrence is determined by glioblastoma stem-like cells (GSCs), which display self-renewal, tumorigenic potential, and increased radio- and chemo-resistance. The G-quadruplex ligand RHPS4 displays in vitro radiosensitizing effect in GBM radioresistant cells through the targeting and dysfunctionalization of telomeres but RHPS4 and Ionizing Radiation (IR) combined treatment efficacy in vivo has not been explored so far.RHPS4 and IR combined effects were tested in vivo in a heterotopic mice xenograft model and in vitro in stem-like cells derived from U251MG and from four GBM patients. Cell growth assays, cytogenetic analysis, immunoblotting, gene expression and cytofluorimetric analysis were performed in order to characterize the response of differentiated and stem-like cells to RHPS4 and IR in single and combined treatments.RHPS4 administration and IR exposure is very effective in blocking tumor growth in vivo up to 65 days. The tumor volume reduction and the long-term tumor control suggested the targeting of the stem cell compartment. Interestingly, RHPS4 treatment was able to strongly reduce cell proliferation in GSCs but, unexpectedly, did not synergize with IR. Lack of radiosensitization was supported by the GSCs telomeric-resistance observed as the total absence of telomere-involving chromosomal aberrations. Remarkably, RHPS4 treatment determined a strong reduction of CHK1 and RAD51 proteins and transcript levels suggesting that the inhibition of GSCs growth is determined by the impairment of the replication stress (RS) response and DNA repair.We propose that the potent antiproliferative effect of RHPS4 in GSCs is not determined by telomeric dysfunction but is achieved by the induction of RS and by the concomitant depletion of CHK1 and RAD51, leading to DNA damage and cell death. These data open to novel therapeutic options for the targeting of GSCs, indicating that the combined inhibition of cell-cycle checkpoints and DNA repair proteins provides the most effective means to overcome resistance of GSC to genotoxic insults." @default.
• W2960420328 created "2019-07-23" @default.
• W2960420328 creator A5008172943 @default.
• W2960420328 creator A5011333973 @default.
• W2960420328 creator A5014145933 @default.
• W2960420328 creator A5017193886 @default.
• W2960420328 creator A5029288318 @default.
• W2960420328 creator A5033913755 @default.
• W2960420328 creator A5069752420 @default.
• W2960420328 creator A5070040632 @default.
• W2960420328 creator A5071553842 @default.
• W2960420328 creator A5080172742 @default.
• W2960420328 date "2019-07-16" @default.
• W2960420328 modified "2023-10-17" @default.
• W2960420328 title "G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells" @default.
• W2960420328 cites W1525895788 @default.
• W2960420328 cites W1540912615 @default.
• W2960420328 cites W1541877559 @default.
• W2960420328 cites W1946594578 @default.
• W2960420328 cites W1969782880 @default.
• W2960420328 cites W1970543200 @default.
• W2960420328 cites W1977476599 @default.
• W2960420328 cites W1985798182 @default.
• W2960420328 cites W1987081807 @default.
• W2960420328 cites W1993469796 @default.
• W2960420328 cites W1994649597 @default.
• W2960420328 cites W1997677948 @default.
• W2960420328 cites W2004154456 @default.
• W2960420328 cites W2004421521 @default.
• W2960420328 cites W2008891940 @default.
• W2960420328 cites W2021191052 @default.
• W2960420328 cites W2028345897 @default.
• W2960420328 cites W2043299645 @default.
• W2960420328 cites W2050072146 @default.
• W2960420328 cites W2060551076 @default.
• W2960420328 cites W2077128382 @default.
• W2960420328 cites W2086486581 @default.
• W2960420328 cites W2089703995 @default.
• W2960420328 cites W2096287682 @default.
• W2960420328 cites W2097969578 @default.
• W2960420328 cites W2103938773 @default.
• W2960420328 cites W2105252420 @default.
• W2960420328 cites W2109894502 @default.
• W2960420328 cites W2112725705 @default.
• W2960420328 cites W2116064571 @default.
• W2960420328 cites W2117767331 @default.
• W2960420328 cites W2118646042 @default.
• W2960420328 cites W2129069151 @default.
• W2960420328 cites W2132346729 @default.
• W2960420328 cites W2133436567 @default.
• W2960420328 cites W2153400045 @default.
• W2960420328 cites W2155957543 @default.
• W2960420328 cites W2159678445 @default.
• W2960420328 cites W2161232591 @default.
• W2960420328 cites W2165400661 @default.
• W2960420328 cites W2167650288 @default.
• W2960420328 cites W2168786243 @default.
• W2960420328 cites W2256095019 @default.
• W2960420328 cites W2416659527 @default.
• W2960420328 cites W2465848447 @default.
• W2960420328 cites W2569221217 @default.
• W2960420328 cites W2587846473 @default.
• W2960420328 cites W2589078946 @default.
• W2960420328 cites W2591294588 @default.
• W2960420328 cites W2619169658 @default.
• W2960420328 cites W2792674109 @default.
• W2960420328 cites W2793902538 @default.
• W2960420328 cites W2838310729 @default.
• W2960420328 cites W2885478367 @default.
• W2960420328 cites W2886984638 @default.
• W2960420328 cites W2894671340 @default.
• W2960420328 doi "https://doi.org/10.1186/s13046-019-1293-x" @default.
• W2960420328 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6636127" @default.
• W2960420328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31311580" @default.
• W2960420328 hasPublicationYear "2019" @default.
• W2960420328 type Work @default.
• W2960420328 sameAs 2960420328 @default.
• W2960420328 citedByCount "21" @default.
• W2960420328 countsByYear W29604203282020 @default.
• W2960420328 countsByYear W29604203282021 @default.
• W2960420328 countsByYear W29604203282022 @default.
• W2960420328 countsByYear W29604203282023 @default.
• W2960420328 crossrefType "journal-article" @default.
• W2960420328 hasAuthorship W2960420328A5008172943 @default.
• W2960420328 hasAuthorship W2960420328A5011333973 @default.
• W2960420328 hasAuthorship W2960420328A5014145933 @default.
• W2960420328 hasAuthorship W2960420328A5017193886 @default.
• W2960420328 hasAuthorship W2960420328A5029288318 @default.
• W2960420328 hasAuthorship W2960420328A5033913755 @default.
• W2960420328 hasAuthorship W2960420328A5069752420 @default.
• W2960420328 hasAuthorship W2960420328A5070040632 @default.
• W2960420328 hasAuthorship W2960420328A5071553842 @default.
• W2960420328 hasAuthorship W2960420328A5080172742 @default.
• W2960420328 hasBestOaLocation W29604203281 @default.
• W2960420328 hasConcept C104317684 @default.
• W2960420328 hasConcept C121608353 @default.
• W2960420328 hasConcept C128473837 @default.
• W2960420328 hasConcept C177336024 @default.
• W2960420328 hasConcept C185592680 @default.
• W2960420328 hasConcept C207001950 @default.

• next